PBYI
Puma Biotechnology·NASDAQ
--
--(--)
--
--(--)
3.77 / 10
Netural
Analyst sentiment is overwhelmingly bullish with a 100% Strong Buy rating from one analyst, yet the historical win rate is 0.0%, tempering conviction. Money flow is positive for small and medium orders (inflow ratios ~0.51) but negative for extra-large blocks (0.493), indicating institutional hesitation. Together, the analyst and fund-flow picture is neutral—optimistic retail flow faces cautious institutional positioning.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-02-28
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for PBYI?
- PBYI holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.77/10 (Netural).
